Role of Bioactive Compounds in The Glycemic Control Effects of Momordica Charantia and Trigonella Foenum-Graecum ( A-Review)
Oriental Journal Of Chemistry · 01.05.2026 · 2 (42) · 518
DOI: 10.13005/ojc/420213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 30.04.2026. Verfasst von Napeesha Mansoori und 1 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This review examines the role of bioactive compounds in the glycemic control effects of Momordica charantia (bitter melon) and Trigonella foenum-graecum (fenugreek), two plants with extensive traditional use and growing scientific validation for diabetes management.Momordica charantia contains several bioactive compounds with hypoglycemic properties, including polypeptide-p (an insulin-like protein), charantin (a steroidal saponin mixture), vicine (an alkaloid glycoside), cucurbitacin triterpenoids, and polysaccharides. Trigonella foenum-graecum seeds contain 4-hydroxyisoleucine (a unique glucose-dependent insulinotropic amino acid), trigonelline (an alkaloid with DPP-IV inhibitory activity), diosgenin (a steroidal saponin), and galactomannan (a viscous soluble fiber). Both plants exert glycemic control through five interconnected mechanisms: (1) enhanced insulin secretion from pancreatic β-cells, (2) improved peripheral insulin sensitivity and GLUT4-mediated glucose uptake, (3) inhibition of carbohydrate-digesting enzymes (α-amylase and α-glucosidase), (4) suppression of hepatic gluconeogenesis, and (5) modulation of gut microbiota with activation of bitter taste receptor (TAS2R)-mediated GLP-1 secretion.While both plants share overlapping mechanisms, fenugreek's 4-hydroxyisoleucine offers glucose-dependent insulin secretion with minimal hypoglycemia risk, whereas bitter melon's primary secretagogues are less glucose-dependent. Fenugreek's high galactomannan content provides physical impediment to glucose absorption, while bitter melon relies more on chemical enzyme inhibition. Preliminary evidence suggests synergistic effects when combining both plants, potentially addressing both insulin deficiency and insulin resistance components of type 2 diabetes.The bioactive compounds in Momordica charantia and Trigonella foenum-graecum exert multi-targeted glycemic control through complementary mechanisms. These plants represent promising evidence-based adjunctive therapies for diabetes management, though further large-scale, long-term randomized controlled trials are needed to establish optimal dosing, standardization protocols, and safety profiles in specific patient populations.
Zitieren
APA
Mansoori, N., & Shukla, R. (2026). Role of Bioactive Compounds in The Glycemic Control Effects of Momordica Charantia and Trigonella Foenum-Graecum ( A-Review). Oriental Journal Of Chemistry, 2(42), 518. https://doi.org/10.13005/ojc/420213
Vancouver
Mansoori N, Shukla R. Role of Bioactive Compounds in The Glycemic Control Effects of Momordica Charantia and Trigonella Foenum-Graecum ( A-Review). Oriental Journal Of Chemistry. 2026;2(42):518. doi:10.13005/ojc/420213
BibTeX
@article{Mansoori2026,
author = {Mansoori, Napeesha and Shukla, Rajesh},
title = {Role of Bioactive Compounds in The Glycemic Control Effects of Momordica Charantia and Trigonella Foenum-Graecum ( A-Review)},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {2},
number = {42},
pages = {518},
doi = {10.13005/ojc/420213}
}
EUVIMED